Delivery Order SPE2DB20D2001-SPE2DB23FM70E
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.24, is for the supply of Orilissa 150 mg tablets. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Orilissa, to support the healthcare needs of the U.S. military and federal government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,425.49 and was awarded on November 9, 2021, with a completion date of November 10, 2021. It is a firm-fixed-price delivery order contract awarded by...
- This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FL2ZS, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,240.01 firm fixed price delivery order is for the supply of 4565810946 ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has a period of performance through September 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMPFJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,474.25 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a performance period through April 2025. The contract is not set aside and is considered an open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,968.60, is for the delivery of ORILISSA 150 mg tablets. There is no set-aside designation associated with this contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,386.08, is for the delivery of ORILISSA 150 MG tablets. The contract has a ceiling value of $10,386.08 and an ultimate completion date of May 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $4,543.38, is for the delivery of Orilissa 150mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 27, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $32,951.99, is for the delivery of ORILISSA 200 mg tablets. It is a firm fixed-price contract with a completion date of November 15, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $156,868.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that is Firm Fixed Price, with a performance period through December 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $5,287.68 and awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM70EDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation that covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 8/24/23 |